Gilead Sciences (GILD) Crosses Pivot Point Resistance at $54.43
22 days 23 hours 20 minutes ago - Financial News Network Online - Pivot Alerts via Comtex

Shares of Gilead Sciences (NASDAQ:GILD) opened today above their pivot of $53.86 and have already reached the first level of resistance at $54.43. Should the shares continue to rise, the resistance pivots of $54.81 and $55.76 will be of interest.

In the past 52 weeks, Gilead Sciences share prices have been bracketed by a low of $21.91 and a high of $55.16 and are now at $54.93, 151% above that low price. In the last five trading sessions, the 50-day moving average (MA) has climbed 1.7% while the 200-day MA has risen 1.1%.

Gilead Sciences (NASDAQ:GILD) defies analysts with a current price ($54.93) 13.3% above its average consensus price target of $47.64. The stock should find initial support at its 50-day moving average (MA) of $45.87 and further support at its 200-day MA of $36.51.

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops, and commercializes therapeutics to advance the care of patients suffering from life-threatening diseases. The Company's primary arees of focus include HIV/AIDS, liver disease and serious cardiovascular and respiratory conditions.

---------------------------------------------------------------------------------------------

Financial News Network Online (FNNO) is a leading provider of digital financial news content for distribution on the web. You can count on FNNO to bring you the latest market news, earnings reports, analyst comments, economic data reports and more. Visit http://www.fnno.com today.